FA2H and fatty acid hydroxylase-associated neurodegeneration: This interest was stimulated by the characterization of the fatty acid 2-hydroxylase (FA2H) in mammals and other higher eukaryotes in 2004, which was later followed by the identification of a human disease (FAHN/SPG35) caused by mutations in the FA2H gene in 2008 (Figure 1A).